Alcohol detox for Coral Springs — CIWA-Ar-guided, medically supervised, discretion assured.

RECO Island is 35 minutes from Coral Springs — Sawgrass east, I-95 north — offering what few Broward inland facilities can match: specialist-level addiction medicine with 24/7 physician oversight and direct in-house transition from detox to residential. Small-census, no waitlists, no third-party handoffs. Neighborhoods from Eagle Trace to Heron Bay send families to the RECO campus because the coastal treatment-community network here has defined South Florida recovery for decades, and because alcohol withdrawal is not something to manage without a physician on the floor.

Coral Springs sits 25 miles inland from RECO Island’s Delray Beach campus — a 35-minute drive up the Sawgrass Expressway and I-95. For families in Eagle Trace, Parkland Isles, Cypress Run, and Heron Bay, the coast offers something Broward’s inland facilities generally do not: specialist-level addiction medicine embedded in the coastal treatment-community network that has defined South Florida recovery for decades. Medical alcohol detox at RECO Island is a small-census, physician-led program with direct in-house transition to residential — no waitlists, no third-party handoffs, no discharge summary faxed across town while a client sits in acute withdrawal.

Alcohol withdrawal is the one substance withdrawal that can kill

Alcohol occupies a specific place in withdrawal medicine. Unlike opioid, stimulant, cannabis, or nicotine withdrawal — each of which is deeply uncomfortable but not directly lethal — alcohol withdrawal carries genuine mortality. Withdrawal seizures, delirium tremens, and the cardiovascular strain of severe autonomic hyperactivity produce a small but real death rate in unsupervised populations. Historic mortality for untreated DTs ran as high as 15-20%; modern medical management reduces that to under 1%, but only when the client is under supervising physician care with 24/7 nursing.

Risk stratification at intake identifies the clients who need the most intensive monitoring. The strongest predictor of a severe course is a history of prior withdrawal seizures or DTs; other risk factors include high daily alcohol volume, long duration of daily drinking, age over 40, concurrent benzodiazepine or GHB dependence, and medical comorbidities — hepatic dysfunction, electrolyte derangement, poorly controlled hypertension. RECO Island’s medical team performs this stratification before the first benzodiazepine dose is given and sets the client’s monitoring interval accordingly.

This is why medical detox for alcohol use disorder is the standard of care, not a lifestyle preference. Attempting to quit cold turkey after years of daily heavy use is not a moral victory — it is a medical risk with a body count, and the risk climbs sharply with each unsupervised prior withdrawal.

CIWA-Ar and symptom-triggered benzodiazepine dosing

The Clinical Institute Withdrawal Assessment for Alcohol, revised — CIWA-Ar — is a ten-item scale that quantifies withdrawal severity: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, orientation, tactile disturbances, auditory disturbances, visual disturbances, and headache. Nursing staff score the scale at defined intervals — every 1 hour for scores above 15, every 2 hours for scores of 8-15, every 4-8 hours for stable clients scoring below 8. The score dictates the next clinical action.

Symptom-triggered dosing — administering a benzodiazepine when the CIWA-Ar score crosses the treatment threshold, typically 8 or 10 — outperforms fixed-schedule dosing on nearly every measured endpoint: total benzodiazepine exposure, length of stay, and time to symptom control. Agent selection is clinical. Chlordiazepoxide is often first-line for uncomplicated withdrawal with intact hepatic function. Lorazepam is preferred when hepatic function is impaired or in older clients because it lacks active metabolites. Diazepam is used when rapid onset and long duration are needed for severe or rapidly escalating presentations.

Adjuncts are used when appropriate. Gabapentin can reduce benzodiazepine requirements in mild-to-moderate withdrawal. Clonidine and beta-blockers manage autonomic symptoms but do not treat the underlying neurotransmitter dysregulation and are never used to replace benzodiazepines in significant withdrawal. Phenobarbital protocols exist for benzodiazepine-refractory presentations and for clients with concurrent long-acting benzodiazepine dependence.

Thiamine, folate, and Wernicke prevention

Chronic heavy alcohol use produces thiamine (vitamin B1) deficiency through poor dietary intake, reduced gastrointestinal absorption, and impaired hepatic storage. Untreated thiamine deficiency causes Wernicke’s encephalopathy — an acute triad of ophthalmoplegia, ataxia, and confusion — and, if allowed to progress, Korsakoff’s syndrome, a chronic amnestic disorder that does not reverse. This is not a rare complication; it is the reason parenteral thiamine is on every properly written alcohol detox order set.

RECO Island’s admission protocol includes parenteral thiamine — 100 mg IM or IV on day one, continued through the detox course — along with folate, magnesium replacement, and a broad-spectrum multivitamin. Parenteral administration is used because oral absorption is unreliable in this population. Glucose is administered after thiamine, not before, because glucose loading in a thiamine-deficient patient can precipitate Wernicke’s encephalopathy. These are not wellness gestures; they are the standard of care, and the cost of skipping them is permanent neurologic damage.

MAT initiation during detox and the transition to residential

Medication-assisted treatment for alcohol use disorder has three FDA-approved options, each with a distinct mechanism and clinical niche. Naltrexone, an opioid receptor antagonist, blunts the reinforcing effects of alcohol and is available as oral 50 mg daily or long-acting injectable Vivitrol 380 mg IM monthly. Acamprosate 666 mg three times daily modulates glutamate and GABA signaling and best suits clients whose primary goal is abstinence maintenance after acute withdrawal has cleared. Disulfiram produces an aversive reaction to alcohol via aldehyde dehydrogenase inhibition and works for a specific, highly motivated subset of clients with reliable supervision at home.

Because naltrexone requires a 7-10 day opioid-free window, medical detox is the natural place to initiate it — the window is guaranteed. Acamprosate is generally started after acute withdrawal has resolved and abstinence is stabilized, typically as clients transition into residential treatment. Disulfiram is discussed in aftercare planning. The MAT decision is made collaboratively — client, medical team, therapist — and documented in the treatment plan, not treated as an afterthought.

The transition from detox to residential at RECO Island is direct: same clinical team, same medical record, no discharge and re-admission. This continuity matters. Clients who complete detox as a standalone episode without immediate transition to structured treatment have first-year relapse rates approaching 90% in national data.

What to expect on the first day at RECO Island

Admission begins with a phone call to the admissions team. Insurance is verified in real time, medical history is taken, and a bed is confirmed before the client leaves Coral Springs. Transportation from Broward County is available and frequently used, since clients in active withdrawal are rarely safe to drive. On arrival at the Delray Beach campus, an admitting nurse completes vitals and intake screening, and a physician performs the medical evaluation and orders initial medications — parenteral thiamine, folate, magnesium, and the first benzodiazepine dose if the CIWA-Ar score is at threshold.

Acute detox typically runs 5-7 days; complicated withdrawal may extend to 10. Direct transition to residential follows without a gap. Clients moving into residential engage in evidence-based individual and group therapy — CBT, DBT skills training, motivational interviewing, and trauma-focused modalities including EMDR where indicated. Psychiatric evaluation for co-occurring depression, anxiety, or PTSD is standard; the PHQ-9 and GAD-7 are used at baseline and re-scored across treatment, and non-addictive pharmacology such as sertraline or buspirone is considered where clinically appropriate.

Insurance and admissions from Coral Springs

RECO Island is in-network with Florida Blue and Blue Cross Blue Shield and works with Aetna, Cigna, UnitedHealthcare, and Humana on out-of-network and single-case-agreement bases. Verification of benefits is completed same-day. Level-of-care recommendations are made against the ASAM Criteria — the six-dimension framework payers use to adjudicate medical necessity for detox and residential care. Coverage for detox is generally strong when the clinical picture supports it, which is the norm for adults with sustained heavy drinking presenting in withdrawal.

The drive from Coral Springs — Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay — is straightforward: Sawgrass Expressway east, I-95 north, exit at Delray. In light traffic it is 35 minutes. Families frequently make the drive for structured family therapy and visitation once the client has cleared acute detox and stabilized in residential treatment.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.